Cerestar excipient offers compression savings
A new directly compressible excipient from Cargill-Cerestar Food & Pharma Specialities, a starch and starch derivatives supplier, enables tablets to be made with lower compression forces.
A new directly compressible excipient from Cargill-Cerestar Food & Pharma Specialities, a starch and starch derivatives supplier, enables tablets to be made with lower compression forces.
C*PharmMannidex DC is a mannitol-based excipient that enables pharmaceutical companies to formulate tablets with higher doses of active ingredients. Its properties are useful for those companies that are looking to switch from animal-derived to non-animal derived excipients.
Mannitol is non-cariogenic and suitable for diabetics but has the added benefits of being non-hygroscopic and chemically stable. Its high compressibility, high binding capacity and low friability makes it an excellent diluent-binder and ideal for use in chewable tablets such as vitamin and antacid formulations.
In addition to mannitol, the company also provides a range of polyol excipients and products for clinical nutrition, such as sorbitol and maltitol, erythritol and isomalt, as well as pre-gelatinised starches, maltodextrins and dextroses.